Emergent Biosolutions
EBS
EBS
340 hedge funds and large institutions have $4.13B invested in Emergent Biosolutions in 2021 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 126 increasing their positions, 138 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
9% less repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 138
4% less funds holding
Funds holding: 353 → 340 (-13)
16% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 50
Holders
340
Holding in Top 10
3
Calls
$12.8M
Puts
$12.8M
Top Buyers
| 1 | +$169M | |
| 2 | +$30.8M | |
| 3 | +$20.1M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$17M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$14.1M |
Top Sellers
| 1 | -$39.2M | |
| 2 | -$22.2M | |
| 3 | -$21.6M | |
| 4 |
Jennison Associates
New York
|
-$21.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.5M |